200956-75-8Relevant articles and documents
Use of NK-1 receptor antagonists for treating major depressive disorders
-
, (2008/06/13)
The present invention provides methods for the treatment of major depressive disorders comprising oral administration of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist and pharmaceutical compositions comprising such a NK-1 receptor
Use of NK-1 receptor antagonists for treating stress disorders
-
, (2008/06/13)
The present invention provides the use of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of stress disorders without concomitant the